tsh biopharmoration Ltd

TSH Biopharm Corporation Limited develops and markets pharmaceutical products in Taiwan. It offers prescription medications for cardiovascular, central nervous system, and gastrointestinal conditions, among others. The company also provides MPap, a methylation-specific qPCR technology for detecting the methylation status of CDO1 and BHLHE22 genes using cervical scraping, along with the AlphaLiquid Detect, AlphaLiquid 100, AlphaLiquid HRR, AlphaSolid, and AlphaSolid HRR liquid and tissue biopsy tests. Founded in 2000 and headquartered in Taipei, Taiwan, it operates as a subsidiary of TTY Biopharm Company Limited.